Allergan Plc (AGN) Return on Investment ROI from the first quarter of 2020 to first quarter of 2019 and for the year 2020, average high and low, overall ranking from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Allergan plc  (NYSE: AGN)


Allergan Plc's ROI from its first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Allergan Plc's ROI in the first quarter of 2020?
Allergan Plc had a negative return on investment (ROI) of -1.76%, due to the net loss of $-2 billion, during the twelve months ending in the first quarter of 2020.

Within the Healthcare sector 215 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2019 from 0 to 2781.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Investment Change TTM -15.16 % -17.86 % -18.88 % -15.32 % -12.69 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 136,872 139,510 140,948 144,570 148,508
Return On Investment (TTM) -1.76 % -3.67 % -6.25 % -5.42 % -4.35 %
AGN's Overall Ranking # 2781 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -2.03 % -3.02 % -5.69 % -5.32 % -5.14 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -2,479 -5,265 -9,244 -8,494 -7,210

AGN Company Profile >> Back to AGN Roi Comparisons >> See Annual AGN Return On Investment



Return On Investment AGN's Ranking
Within: No.
Industry # 64
Sector # 216
Overall # 2781

Return On Investment Statistics
High Average Low
20.71 %
5.91 %
-6.24 %
(Dec. 31. 2005)   (Sep 30 2019)







Financial Statements
Allergan Plc's I. Quarter Investments $ 136,872 Millions AGN's Balance sheet
Allergan Plc's I. Quarter Income $ 379 Millions Quarterly AGN's Income Statement
AGN's Income by Division See AGN's Income by Division


AGN Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 139,498 157,368 188,186 208,311 203,086
Y / Y Investment Growth -11.36 % -16.38 % -9.66 % 2.57 % 1770.31 %
Net Income in Millions -5,265 -5,086 -4,119 14,980 3,919
Y / Y Net Income Growth - - - 282.19 % 157.14 %
Annual Return On Investment -3.77 % -3.23 % -2.19 % 7.19 % 1.93 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AGN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AGN's Competitors
Subscribers only: Roi for Allergan Plc's Suppliers
Subscribers only: Return On Investment for AGN's Customers

Other Ratios
AGN's Roa AGN's Inventory Turnover Ratio AGN's Growth Rates AGN's Dividend Statistics
AGN's Profitability Ratios AGN's Asset Turnover Ratio AGN's Dividend Growth
AGN's Roe AGN's Valuation Ratios AGN's Financial Strength Ratios AGN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2020, within Healthcare Sector ROI

Date modified: 2026-09-26T07:20:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.